Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olujide O Olubiyi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Physical Chemistry. B|February 4, 2012
Structures of the amyloid β-peptides Aβ1-40 and Aβ1-42 as influenced by pH and a D-peptideOlujide O Olubiyi, Birgit Strodel
Data in Brief|October 22, 2016
Topology and parameter data of thirteen non-natural amino acids for molecular simulations with CHARMM22Olujide O Olubiyi, Birgit Strodel
Chemical Communications (Cambridge, England)|January 29, 2014
Early amyloid β-protein aggregation precedes conformational changeBogdan Barz, Olujide O Olubiyi, Birgit Strodel
International Journal of Molecular Sciences|November 13, 2021
The Influences of Sulphation, Salt Type, and Salt Concentration on the Structural Heterogeneity of GlycosaminoglycansSuman Samantray, Olujide O Olubiyi, Birgit Strodel
Molecules (Basel, Switzerland)|December 18, 2019
Rational Drug Design of Peptide-Based Therapies for Sickle Cell DiseaseOlujide O Olubiyi, Maryam O Olagunju, Birgit Strodel
Current Computer-Aided Drug Design|September 17, 2016
Computational Analysis of Physicochemical Factors Driving CYP2D6 Ligand InteractionOlujide O Olubiyi, Maryam O Olagunju, Abiola O Obisesan
Proteins|April 27, 2022
Multiscale MD simulations of wild-type and sickle hemoglobin aggregationMaryam O Olagunju, Jennifer Loschwitz, Olujide O Olubiyi, et al.
Current Computer-Aided Drug Design|March 23, 2018
Structural Optimization of Mangiferin Binding to Cancer Molecular Targets: A Guide for Synthetic DerivatizationBamigboye J Taiwo, Olujide O Olubiyi, Fanie R van Heerden
Current Computer-Aided Drug Design|July 4, 2019
Computational Prospecting for the Pharmacological Mechanism of Activity: HIV-1 Inhibition by Ixoratannin A-2Olujide O Olubiyi, Thomas O Idowu, Abiodun O Ogundaini, et al.
Molecules (Basel, Switzerland)|July 17, 2020
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2Olujide O Olubiyi, Maryam Olagunju, Monika Keutmann, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Physical Chemistry. B|February 4, 2012
Structures of the amyloid β-peptides Aβ1-40 and Aβ1-42 as influenced by pH and a D-peptideOlujide O Olubiyi, Birgit Strodel
Data in Brief|October 22, 2016
Topology and parameter data of thirteen non-natural amino acids for molecular simulations with CHARMM22Olujide O Olubiyi, Birgit Strodel
Chemical Communications (Cambridge, England)|January 29, 2014
Early amyloid β-protein aggregation precedes conformational changeBogdan Barz, Olujide O Olubiyi, Birgit Strodel
International Journal of Molecular Sciences|November 13, 2021
The Influences of Sulphation, Salt Type, and Salt Concentration on the Structural Heterogeneity of GlycosaminoglycansSuman Samantray, Olujide O Olubiyi, Birgit Strodel
Molecules (Basel, Switzerland)|December 18, 2019
Rational Drug Design of Peptide-Based Therapies for Sickle Cell DiseaseOlujide O Olubiyi, Maryam O Olagunju, Birgit Strodel
Current Computer-Aided Drug Design|September 17, 2016
Computational Analysis of Physicochemical Factors Driving CYP2D6 Ligand InteractionOlujide O Olubiyi, Maryam O Olagunju, Abiola O Obisesan
Proteins|April 27, 2022
Multiscale MD simulations of wild-type and sickle hemoglobin aggregationMaryam O Olagunju, Jennifer Loschwitz, Olujide O Olubiyi, et al.
Current Computer-Aided Drug Design|March 23, 2018
Structural Optimization of Mangiferin Binding to Cancer Molecular Targets: A Guide for Synthetic DerivatizationBamigboye J Taiwo, Olujide O Olubiyi, Fanie R van Heerden
Current Computer-Aided Drug Design|July 4, 2019
Computational Prospecting for the Pharmacological Mechanism of Activity: HIV-1 Inhibition by Ixoratannin A-2Olujide O Olubiyi, Thomas O Idowu, Abiodun O Ogundaini, et al.
Molecules (Basel, Switzerland)|July 17, 2020
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2Olujide O Olubiyi, Maryam Olagunju, Monika Keutmann, et al.
Pageof 2